Anti-Cancer Agents in Medicinal Chemistry, Volume 7 - Number 3

The Bright Future of Radionuclides for Cancer Therapy

, 7(3): 271 - 290

Johannes Franciscus Wilhelmus Nijsen, Gerard Cornelis Krijger and Afred Dirk van het Schip

DOI: 10.2174/187152007780618207

MRI Contrast Agents: Current Status and Future Perspectives

, 7(3): 291 - 305

Gustav J. Strijkers, Willem J. M. Mulder, Geralda A. F. van Tilborg and Klaas Nicolay

DOI: 10.2174/187152007780618135

Factors Affecting the Sensitivity and Detection Limits of MRI, CT, and SPECT for Multimodal Diagnostic and Therapeutic Agents

, 7(3): 317 - 334

Peter R. Seevinck, Jan-Henry Seppenwoolde, Tim C. de Wit, Johannes F. W. Nijsen, Freek J. Beekman, Alfred D. van het Schip and Chris J. G. Bakker

DOI: 10.2174/187152007780618153

Radionuclide Therapy of Cancer with Radiolabeled Antibodies

, 7(3): 335 - 343

Wim J. Oyen, E. J. Postema, Frans H. Corstens, Otto C. Boerman and Manuel J. Koppe

DOI: 10.2174/187152007780618126

Radiolabelled Regulatory Peptides for Imaging and Therapy

, 7(3): 345 - 357

M. de Jong, T. J. Visser, E. de Blois, W. A. P. Breeman, D. J. Kwekkeboom and E. P. Krenning

DOI: 10.2174/187152007780618171

Webmaster Contact:
Copyright © 2018 Bentham Science